FDA Pressure Likely In Novartis OTC Plant Shutdown, Recalls
By
Dan Schiff / Email the Author / Health News Daily Feb. 1, 2012
Today's Stories / Word Count: 866 / Article # 29120201001
Executive Summary
FDA inspectors were in Novartis Consumer Health’s Lincoln, Neb., plant in December and January, as the company was deciding to halt production and recall products. An inspection report notes 10 observations – eight of them repeats from FDA’s visit in mid-2011.
$50.00
Buy Now
For $50.00, purchase this 866-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.